Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	139	125	69	75	62	173
Market Cap Growth	56.01%	81.17%	-7.22%	20.46%	-64.21%	-
Enterprise Value	116	102	66	73	49	159
Last Close Price	6.80	6.80	4.51	5.16	4.80	16.55
PS Ratio	11.73	10.55	4.73	29.57	34.66	146.97
PB Ratio	7.23	6.50	8.00	13.20	3.69	5.94
P/TBV Ratio	7.23	6.50	8.00	13.20	3.69	5.94
EV/Sales Ratio	9.75	8.60	4.52	28.83	27.67	135.29
Net Debt / Equity Ratio	-1.22	-1.22	-0.70	-0.59	-0.92	-0.41
Net Debt / EBITDA Ratio	2.26	2.26	4.77	-	-	-
Net Debt / FCF Ratio	6.38	6.38	4.58	0.19	0.78	1.24
Asset Turnover	0.56	0.56	1.27	0.18	0.07	0.07
Quick Ratio	2.64	2.64	1.36	1.11	5.80	5.51
Current Ratio	2.73	2.73	2.15	2.02	6.33	5.60
Return on Equity (ROE)	-74.82%	-74.82%	-15.37%	-149.06%	-84.39%	-61.97%
Return on Assets (ROA)	-31.36%	-31.36%	-7.29%	-73.14%	-47.73%	-33.40%
Return on Capital Employed (ROCE)	-54.80%	-54.80%	-15.50%	-299.20%	-115.90%	-31.50%
Earnings Yield	-7.50%	-8.33%	-1.59%	-22.40%	-31.28%	-5.29%
FCF Yield	-2.64%	-2.94%	-1.92%	-23.73%	-31.78%	-5.59%
Buyback Yield / Dilution	-5.59%	-5.59%	-18.42%	-13.66%	-14.64%	-45.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.